May 29, 2019
06:00 PM - 08:00 PM (America/New_York)
Nevakar Inc, NJCOE, 1019 Route 202/206, Bldg K
Bridgewater,United States View map →

This event has ended. Please contact organizer for more details.

Report Issues



There are leaders and there are those who lead.

Leaders hold a position of power or influence.

Those who lead inspire us.

We welcome you to engage with a group of serial entrepreneurs and intrapreneurs who will share their insights and experiences stemming from their journey, leading to their success.  These experiences and insights are meant to inspire and benefit folks who may be at various stages of their own journey of entrepreneurship. 


·       Jassi Chadha, President & CEO of Axtria

·       Don DeGolyer, Founder & CEO, Vertice Pharma 

·       Dr. Raj Lakhanpal, Founder and CEO, SpectraMedix 

Dr. Navneet Puri: Founder and CEO, Nevakar


·       6:00-6:45 pm: Cocktails & Hors d'oeuvres

·       6:45-8:00pm: Fireside Chat and Q&A

If you are an entrepreneur, pharma executive or an aspiring entrepreneur, you won't want to miss this very interesting event!!!


Dr. Navneet Puri, Founder and CEO, Nevakar 

Dr. Puri is a pharmacist by education with 20 years of healthcare industry experience. He founded Nevakar in 2015 with a vision of creating a fully integrated specialty pharmaceutical company focusing on hospital injectables and ophthalmic products. 

Prior to Nevakar, Dr Puri spent several years in product development and drug delivery of parenteral pharmaceuticals at Baxter Healthcare Corp. and Amgen Inc. He founded InnoPharma, Inc. in 2005, focusing on development of complex generic injectable dosage formulations. When Pfizer acquired InnoPharma in 2014, he stayed on as Vice President of Pfizer’s Worldwide Research & Development until 2015.

Dr. Puri received Future 50 magazine’s Smart CEO award in 2015. He was also awarded the EY Entrepreneur of The Year award from the state of NJ in 2015. 

Dr Puri’s past board positions include InnoPharma, Eyenuk and Xeris Pharmaceuticals.  His current board positions include Nevakar, Alzeca Biosciences and Rutgers Biomedical and Health Sciences Leadership Council.

Dr. Puri earned a MS from the University of Mississippi and a PhD in Pharmaceutics from Rutgers University.


Jassi Chadha: President & CEO of Axtria

Jassi is President & CEO of Axtria, a leading provider of Big Data and Cloud-computing business solutions for the Life Sciences industry. Axtria has been recognized as one of the fastest growing technology company by Deloitte fast 500, Red Herring 100, INC 500 and NJ Biz Magazine.

Jassi is a member of Board of Ocular Therapeutics [NASDAQ: OCUL] and SpectraMedix. Jassi is a 2-time winner of New Jersey E&Y "Entrepreneur of the Year" award, was named "Top Forty under Forty" by NJBiz Magazine, honored with “Lifetime Achievement Award” by Pharmaceutical Management Science Association, and named to the PharmaVOICE 100, which recognizes the 100 most influential people in the life sciences industry.

In recognition of his service and achievements, Jassi was awarded Distinguished Alumni Service Award by IIT Delhi in 2008.

Jassi received his B.Tech in Mechanical Engineering from IIT Delhi in 1990, M.S. in Industrial Engineering from The University of Texas at El Paso in 1992, was a Doctoral candidate (ABD)  in Operations Research at Texas A&M University until 1995 and graduated from Owners President Program (OPM) from Harvard Business School in 2017.

Don DeGolyer, Founder & CEO, Vertice Pharma

Don DeGolyer has built both a successful and significant career in healthcare by recognizing emerging trends and gaining the operational knowledge to effectively lead his teams to extraordinary results. Don has been the CEO and Board Member of Vertice Pharma since November 2015. Vertice is a specialty pharmaceuticals company focused on improving patients’ health, with headquarters in New Jersey.

Previously, Don was the COO of Endo Pharmaceuticals, where he led the fastest growing U.S. generic business, completed six acquisitions and created more than $12 Billion dollars of shareholder value. Earlier, he served as President & CEO of Sandoz North America with sales of $3.5 billion. Sandoz, the generics division of Novartis, is the second largest generics company in the world.

Don began his career at Pfizer, Johnson & Johnson and then Novartis progressing through various roles of increasing responsibility. Prior to joining Novartis in 2002, Don was the President of Global Therapeutics at publicly traded Oxford GlycoSciences, a world leader in proteomics and rare diseases. Don received his undergraduate degree from the University of Rochester and his MBA from Fairleigh Dickinson University. He served on the Executive Committee of Board of Directors for the Generic Pharmaceutical Association (GPhA), and has also served on the Board of the Red Cross for NJ. 

Dr. Raj Lakhanpal, Founder and CEO, SpectraMedix

Raj is the founder and CEO of SpectraMedix, a company with clinical analytics solutions to transform real-time data into predictive, actionable analytics. 

Previously he founded HealthAtoZ, a top online wellness and population health management platform with deep analytics capabilities. HealthAtoZ was acquired by OptumHealth, a division of UnitedHealth Group in 2006.

Raj is a former emergency physician and associated as Fellow of the Royal College of Physicians and Surgeons in the UK. He serves on Board of Trustees of the University of Sciences in Philadelphia, and a Lifetime member of AAPI. Last but not least, he is the founder of TiE New Jersey Chapter. 

  1. ​Nevakar Inc, NJCOE,
    1019 Route 202/206, Bldg K,
    Bridgewater, New Jersey, United States
    View map →

Organiser : TiE New Jersey

TiE New Jersey and AAiPS

TiE is powered by Explara. Explara uses cookies to enhance your experience. By using our site, you agree to our privacy policy.


Ask Organiser

Report spam or issues